Navidea Biopharmaceuticals Valuation
| NAVBDelisted Stock | USD 0.08 0 2.63% |
Navidea Biopharmaceutica seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Navidea Biopharmaceutica from analyzing the firm fundamentals such as Current Valuation of 3.5 M, return on equity of -11.0, and Shares Owned By Insiders of 35.43 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Navidea Biopharmaceutica's price fluctuation is very steady at this time. Calculation of the real value of Navidea Biopharmaceutica is based on 3 months time horizon. Increasing Navidea Biopharmaceutica's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Navidea Biopharmaceuticals is useful when determining the fair value of the Navidea pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Navidea Biopharmaceutica. Since Navidea Biopharmaceutica is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Navidea Pink Sheet. However, Navidea Biopharmaceutica's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0779 | Real 0.0739 | Hype 0.08 |
The real value of Navidea Pink Sheet, also known as its intrinsic value, is the underlying worth of Navidea Biopharmaceutica Company, which is reflected in its stock price. It is based on Navidea Biopharmaceutica's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Navidea Biopharmaceutica's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Navidea Biopharmaceutica's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Navidea Biopharmaceuticals helps investors to forecast how Navidea pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Navidea Biopharmaceutica more accurately as focusing exclusively on Navidea Biopharmaceutica's fundamentals will not take into account other important factors: Navidea Biopharmaceutica Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Navidea Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Navidea Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Navidea Biopharmaceutica competition to find correlations between indicators driving Navidea Biopharmaceutica's intrinsic value. More Info.Navidea Biopharmaceuticals is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies fabricating about 15.40 of Price To Book per Price To Earning. Comparative valuation analysis is a catch-all model that can be used if you cannot value Navidea Biopharmaceutica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Navidea Biopharmaceutica's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Navidea Biopharmaceutica's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Navidea Biopharmaceutica's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Navidea Biopharmaceutica and how it compares across the competition.
About Navidea Biopharmaceutica Valuation
The pink sheet valuation mechanism determines the current worth of Navidea Biopharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Navidea Biopharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Navidea Biopharmaceutica based exclusively on its fundamental and basic technical indicators. By analyzing Navidea Biopharmaceutica's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Navidea Biopharmaceutica's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Navidea Biopharmaceutica. We calculate exposure to Navidea Biopharmaceutica's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Navidea Biopharmaceutica's related companies.Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio. Navidea Biopharmaceutica operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 11 people.
8 Steps to conduct Navidea Biopharmaceutica's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Navidea Biopharmaceutica's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Navidea Biopharmaceutica's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Navidea Biopharmaceutica's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Navidea Biopharmaceutica's revenue streams: Identify Navidea Biopharmaceutica's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Navidea Biopharmaceutica's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Navidea Biopharmaceutica's growth potential: Evaluate Navidea Biopharmaceutica's management, business model, and growth potential.
- Determine Navidea Biopharmaceutica's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Navidea Biopharmaceutica's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Navidea Biopharmaceutica Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Navidea Biopharmaceutica does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 29.3 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Navidea Pink Sheet
If you are still planning to invest in Navidea Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Navidea Biopharmaceutica's history and understand the potential risks before investing.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |